Hereditary blood coagulation disorders: management and dental treatment. J Dent Res 2005 Nov;84(11):978-985.
A model for the stoichiometric regulation of blood coagulation. J Biol Chem 2002 May;277(21):18322-18333.
The dental management of adult patients with haemophilia and other congenital bleeding disorders. Haemophilia 2003 Nov;9(6):673-677.
Haemophilia. Ind Pediat 2000;37:45-53.
Bleeding disorders: characterization, dental considerations and management. J Can Dent Assoc 2006 Nov;72(9):827.
A protocol for the dental management of von Willebrand's disease, Hemophilia A and Hemophilia B. Aust Dent J 2001 Mar;46(1):37-40.
Management of dental extraction in patients with Hemophilia A and B: a report of 58 extractions. Med Oral Patol Oral Cir Bucal 2014 Jan;19(1):e55-e60.
Pharmacokinetics of coagulation factors: clinical relevance for patients with hemophilia. Clin Pharmacokinet 2001;40(11):815-832.
Recombinant FIX recovery and inhibitor safety: a Canadian post-licensure surveillance study. Thromb Hemost 2002 Mar;87(3):431-435.
Guidelines for the management of hemophilia. Hemophilia 2013 Jan;19(1):e1-e47.
Prevalence of inhibitors in a population of 3435 hemophilia patients in France. Thromb Haemost 1992 Jun;67(6):600-602.
Factor VIII inhibitors in mild and moderate severity haemophilia A. UK Haemophilia Centre Directors Organisation. Thromb Haemost 1998 Apr;79(4):762-766.
Haemophilia A: mutation type determines risk of inhibitor formation. Thromb Haemost 1995 Dec;74(6):1402-1406.
Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII. Lancet 1993 Aug;342(8869):462-464.
HLA class II profile: a weak determinant of factor VIII inhibitor development in severe hemophilia A. Thromb Haemost 1997 Feb;77(2):234-237.
HLA genotype of patients with severe hemophilia A due to intron 22 inversion with and without inhibitors to factor VIII. Thromb Haemost 1997 Feb;77(2):238-242.
Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with hemophilia and high responding inhibitors. Br J Haematol 2002 Mar;116(3):632-635.
Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997 Oct;90(7):2515-2521.
Desmopressin for the treatment of haemophilia. Haemophilia. 2008;14(Suppl 1):15-20.
Bleeding disorders of importance in dental care and related patient management. J Can Dent Assoc 2007 Feb;73(1):77-83.
The use of locally prepared fibrin glue in dental extractions of patients with bleeding disorders. Haemophilia 1998;4(3):302.
Dental surgical management of hemophilia patients with inhibitors. Haemophilia 1998;4:305.
Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000-2002). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 Mar;99(3):270-275.
Dental management of haemophilic pediatric patients. Pak Oral Dent J 2012 Jun;32(1):66-70.
Guidance on the dental management of patients with haemophilia and congenital bleeding disorders. Br Dent J 2013 Nov;215(10):497-504.
Comparative in vitro analysis of topical hemostatic agents. J Surg Res 1996 Dec;66(2):100-108.
Dental management of hemophiliac child under general anesthesia. J Indian Soc Pedod Prev Dent 2011 Jan-Mar;29(1):74-79.
Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery. J Oral Maxillofac Surg 2003 Dec;61(12):1405-1409.
Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers. Haemophilia 2005 Sep;11(5):504-509.
